Literature DB >> 19635609

Protection against anthrax and plague by a combined vaccine in mice and rabbits.

Jun Ren1, Dayong Dong, Jinlong Zhang, Jun Zhang, Shuling Liu, Bing Li, Ling Fu, Junjie Xu, Changming Yu, Lihua Hou, Jianmin Li, Wei Chen.   

Abstract

The protective antigen (PA) of Bacillus anthracis and the Fraction 1 Capsular Antigen (F1 antigen), V antigen of Yersinia pestis have been demonstrated to be potential immunogens and candidate vaccine sub-units against anthrax and plague respectively. In this study, the authors have investigated the antibody responses and the protective efficacy when the antigens were administered separately or in combination intramuscularly formulation adsorbed to an aluminum hydroxide adjuvant. Results show that immunized rF1 + rV and rPA antigen together was as effective as separately for induction of serological antibody response, and these titers were maintained for over 1 year in mice. An isotype analysis of the serum indicates that the co-administration of these antigens did not influence the antigen-specific IgG1/IgG2a ratio which was consistent with a Th2 bias. Furthermore, the combined vaccine comprising the protein antigens rF1 + rV + rPA has been demonstrated to protect mice from subcutaneous challenge with 10(7) colony-forming units (CFU) virulent Y. pestis strain, and to fully protect rabbit against subcutaneous challenge with 1.2x10(5) colony-forming units (CFU) virulent B. anthracis spores. These data show that the protective efficacy was unaffected when the antigens were administered in combination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635609     DOI: 10.1016/j.vaccine.2009.07.015

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  A chimeric protein that functions as both an anthrax dual-target antitoxin and a trivalent vaccine.

Authors:  Gaobing Wu; Yuzhi Hong; Aizhen Guo; Chunfang Feng; Sha Cao; Cheng-Cai Zhang; Ruiping Shi; Yadi Tan; Ziduo Liu
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

2.  Identification and characterization of a neutralizing monoclonal antibody that provides complete protection against Yersinia pestis.

Authors:  Weicen Liu; Jun Ren; Jinlong Zhang; Xiaohong Song; Shuling Liu; Xiangyang Chi; Yi Chen; Zhonghua Wen; Jianmin Li; Wei Chen
Journal:  PLoS One       Date:  2017-05-09       Impact factor: 3.240

3.  A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Bacillus anthracis and Yersinia pestis.

Authors:  Pan Tao; Marthandan Mahalingam; Jingen Zhu; Mahtab Moayeri; Michelle L Kirtley; Eric C Fitts; Jourdan A Andersson; William S Lawrence; Stephen H Leppla; Ashok K Chopra; Venigalla B Rao
Journal:  Front Immunol       Date:  2017-06-26       Impact factor: 7.561

4.  Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis.

Authors:  Theresa B Gallagher; Gabriela Mellado-Sanchez; Ana L Jorgensen; Stephen Moore; James P Nataro; Marcela F Pasetti; Les W Baillie
Journal:  PLoS Negl Trop Dis       Date:  2019-08-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.